ORCHID BIOSCIENCES INC 4
4 · ORCHID BIOSCIENCES INC · Filed Mar 14, 2005
Insider Transaction Report
Form 4
SAMANA CAPITAL, L.P.
Other
Transactions
- Purchase
Common Stock
2005-03-10$12.15/sh+16,609$201,799→ 2,300,000 total - Purchase
Common Stock
2005-03-10$12.09/sh+100$1,209→ 2,247,351 total - Purchase
Common Stock
2005-03-10$12.12/sh+960$11,635→ 2,277,791 total - Purchase
Common Stock
2005-03-10$12.13/sh+5,500$66,715→ 2,283,291 total - Purchase
Common Stock
2005-03-10$12.07/sh+400$4,828→ 2,242,291 total - Purchase
Common Stock
2005-03-10$12.08/sh+4,960$59,917→ 2,247,251 total - Purchase
Common Stock
2005-03-10$12.10/sh+25,780$311,938→ 2,273,131 total - Purchase
Common Stock
2005-03-10$12.11/sh+3,700$44,807→ 2,276,831 total
Footnotes (2)
- [F1]This statement is being filed by Ziff Asset Management, L.P. ("Ziff Asset Management"), PBK Holdings, Inc. ("PBK Holdings") and Philip B. Korsant ("Korsant").
- [F2]Ziff Asset Management beneficially owns directly the shares of Orchid BioSciences, Inc. common stock, par value $0.001 per share ("Common Stock"), reported above. PBK Holdings, as the general partner of Ziff Asset Management, and Korsant, as the sole shareholder of PBK Holdings, may be deemed indirect beneficial owners of the Common Stock owned by Ziff Asset Management. PBK Holdings and Korsant each disclaims beneficial ownership of the Common Stock reported above except to the extent of its pecuniary interest therein.